Phase 4 N=114 Randomized Control Trial of a Topical Anesthetic to Evaluate Pain and Anxiety During Venipuncture
Pain · Anxiety
Primary: Pain From Venipuncture — 2.2; 2.1 scores on a scale — p=0.71
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=40 Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines
Glabellar Frown Lines
Primary: Percentage of Participants With Improvement in Subject Global Assessment of Change at Day 30 — 94.7; 0.00 Percentage of participants
Phase 4 N=24 Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults
Attention Deficit Hyperactivity Disorder (ADHD)
Primary: Left Ventricle Size — 44.42; 43.57 mm
Phase 4 N=59 A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber
Rhinitis, Allergic, Perennial · Allergic Rhinitis
Primary: Weighted Mean Total Nasal Symptom Score (TNSS) at 2-5 Hours Post-dose (1-4 Hours Post-start of Challenge [PSC]) in the Vienna Challenge Chamber (VCC) — 7.17; 5.54; 5.66…
Phase 4 N=20 Iron Bioavailability of Fortified Oat Drink
Iron Absorption
Primary: Percent Iron Absorption — 7.14; 5.65 percentage of Iron absorbed
Phase 4 N=91 Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study
Erosive Esophagitis
Primary: Percent of Subjects Overall Who Healed, Improved, or Stayed the Same or Worsened After 8 Weeks of Treatment — 83; 81; 15; 14 percentage of patients — p=1.0
Phase 4 N=132 Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence
Urinary Bladder, Overactive
Primary: Change in OAB Symptoms Post Pubovaginal Sling Operation — 63; 21; 4 participants — p=0.001
Phase 4 N=20 Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.
Smoking
Primary: Continuous Abstinence at 12 Weeks Post Target Quit Date — 3; 2 participants
Phase 4 N=12 Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
Breast Cancer · Osteoporosis · Osteopenia
Primary: Change in Intestinal Calcium Absorption Related to Aromatase Inhibitor Therapy — 16 percent calcium absorption
Phase 4 N=16 The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers
Healthy
Primary: Area Under the Concentration Time Curve for Tenofovir, Emtricitabine and Efavirenz — 58.7; 56.7; 10.9; 10.8 mg*hr/mL — p=<0.05
Phase 4 N=19 Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
Osteoporosis · Osteopenia · Vitamin D Deficiency
Primary: Change in Intestinal Calcium Absorption From Baseline to One Month — 3 percent calcium absorption
Phase 4 N=43 Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts
Deep Partial Thickness Burn · Full Thickness Burns
Primary: VAS Score for Pain Before Dressing Removal — 11.0; 4.0 units on a scale
Phase 4 N=25 Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
Schizophrenia · Schizoaffective Disorder · Schizophreniform Disorders
Primary: Change in Waist Circumference — 106.09; 108.37 cm
Phase 4 N=38 Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
Schizophrenia · Insulin Resistance
Primary: Change in Total Cholesterol — -15.3; 5.6 mg/dL — p=0.125
Phase 4 N=1,260 Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis
Perennial Allergic Rhinitis
Primary: Percentage of Subjects With Clinically Relevant Change From Baseline (Day 0) in Nasal Examination Parameters to Exit (Month 12 or Sooner) — 0.8; 1.3; 0.3; 0.8 Percentage…